Original ResearchCMR Imaging Assessing Viability in Patients With Chronic Ventricular Dysfunction Due to Coronary Artery Disease: A Meta-Analysis of Prospective Trials
Under an Elsevier user license
open archive
Key Words
cardiac magnetic resonance
left ventricular dysfunction
myocardial viability
revascularization
Abbreviations and Acronyms
CABG
coronary artery bypass graft
CAD
coronary artery disease
CI
confidence interval
CMR
cardiac magnetic resonance
DE
contrast delayed enhancement
DSE
dobutamine stress echocardiography
EDWT
end-diastolic wall thickness
LDD
low-dose dobutamine
LV
left ventricular
MRI
magnetic resonance imaging
NPV
negative predictive value
PCI
percutaneous coronary intervention
PET-FGD
positron emission tomography with fluorine-18 deoxyglucose
PPV
positive predictive value
QUADAS
quality assessment of diagnostic accuracy studies instrument
ROC
receiver-operating characteristic
SPECT
single-photon emission computed tomography
Cited by (0)
Dr. Garcia is a consultant to TheHeart.org. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The use of gadolinium contrast agents for myocardial imaging is not an FDA approved indication.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.